Treatments to improve cardiorenal outcomes in CKD. ‘Known knowns and known unknowns'
Boehringer-Ingelheim and Lilly Alliance has provided funding towards this educational programme. The Alliance has had no editorial input or influence on the agenda, collateral content of this meeting including the selection of speakers.